PART I . As used in this Annual Report, unless the context indicates or otherwise requires, ARS, ARS Pharma, the company, we, us, our, and other similar terms refer to ARS Pharmaceuticals, Inc., a Delaware corporation and its consolidated subsidiaries. neffy and EURneffy are trademarks of ours that we use in this Annual Report. This Annual Report also includes trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, our trademarks and trade...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-097478 | EDGAR | 112K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042320 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034689 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009491 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005202 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001193125-21-098283 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-273111 | EDGAR | 81K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-107618 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-070900 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000950170-24-125924 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091776 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056967 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061996 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041310 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021997 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000950170-22-021234 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016840 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009694 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-09 | 0001193125-26-097467 | EDGAR | 4K words |
| 2025-11-10 | 0001193125-25-273107 | EDGAR | — |
| 2025-09-29 | 0001193125-25-223228 | EDGAR | — |
| 2025-08-28 | 0001193125-25-190202 | EDGAR | — |
| 2025-08-13 | 0000950170-25-107617 | EDGAR | — |
| 2025-06-26 | 0001193125-25-148922 | EDGAR | — |
| 2025-05-14 | 0000950170-25-070899 | EDGAR | — |
| 2025-05-02 | 0001193125-25-110696 | EDGAR | — |
| 2025-03-20 | 0000950170-25-042317 | EDGAR | — |
| 2025-03-05 | 0001193125-25-047351 | EDGAR | — |
93 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671858 |
| Ticker | SPRY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ars-pharma.com |
| Listed | 2022-11-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report